Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Effect of Multisensory (Snoezelen) Environment on Birth Outcomes

NCT06732544 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-09-08
Last updated
2024-12-13

Condition(s) studied

Healthy

Investigational drug(s) / intervention(s)

snoezelen roomroutine delivery room

snoezelen room: During the travail, projectors, starry ceiling visuals and blue light LEDs will be used for visual stimuli, speakers will be used as auditory stimuli, diffusers will be used for olfactory stimuli, and therapy dough will be used for touch stimuli.

routine delivery room: General practice

Study summary

Giving birth is a fundamental life event that women will remember throughout their lives. While seeking perfection for the birth environment, much can be learned from other areas of expertise and different pursuits can be undertaken. An example of this is "Snoezelen rooms". In the Snoezelen environment, it is aimed to relax the woman by stimulating various senses, including visual and auditory, and by diverting attention. The room design is a combination of light music, aquarium, optical illusions and aromatic oils. This study will be conducted in a randomized controlled manner to examine the effects of a multi-sensory (snoezelen) environment on birth outcomes, newborn health parameters and birth memory.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Those who are between the ages of 18-35 * Having a singleton pregnancy between 38-42 weeks of pregnancy * Primiparous * Labor started spontaneously * In the latent phase of labor * Without uterine contraction anomaly * The leading part of the fetus is the head (in vertex position) * No analgesia was applied * There is no indication for cesarean section * Amniotomy is not performed * Fetal weight over 2500 g, fetal weight not over 4000 gr * Pregnant women who do not have communication problems will be included in the study. Exclusion Criteria: * Reporting hearing, vision, smell and balance problems * Allergy, asthma, COPD, migraine, vertigo, epilepsy, etc. * Declaring that they have a chronic disease * Declaring that they have a psychiatric history or a diagnosed psychological disorder * Declaring that they have a risky health condition related to pregnancy (preeclampsia, gestational DM, etc.), * Those who report smoking, alcohol and/or substance use * Reports that he/she has sensory sensitivity * Declaring an allergy to lavender (Lavandula angustifolia Mill.) or lavender oil * Declaring that there is a person with special needs in the family * Participated in the study voluntarily and then gave up * Pregnant women who develop any possible side effects during the study will not be included in the study.

Primary outcome measure(s)

  • Personal information form — on admission to the hospital
    With this form, developed by the researcher taking into account literature knowledge, data on women\'s demographic information such as age, education level, and obstetric characteristics such as whether the pregnancy is planned and the current gestational week will be obtained (Hauck et al., 2008; Manesh et al. 2015).
  • birth follow-up form — at the beginning of the third stage of childbirth
    With the follow-up form prepared to evaluate the birth process using the literature, the duration of the stages during labor and the synthetic oxytocin status used will be evaluated. While these practices are evaluated, the researcher will be present in the environment only as an observer, and the practices determined as a result of the observation will be noted on the Birth Monitoring Form (Olcese et al., 2013 Momeni et al., 2020).
  • Birth Memory and Recall Scale — 24 hours after birth
    In order to evaluate women\'s postpartum birth memories, their birth memories, and their experiences regarding birth memories, DHHÖ conducted a study by Foley et al. (2014). It was adapted into Turkish by Topkara \& Çağan (2021).

Trial sites (1)

FacilityCityRegionStatus
Amasya University Hospital Amasya Amasya
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06732544 on ClinicalTrials.gov ↗ ← All trials in Turkey